(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VIVITOXIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

VIVITOXIN

ST13

US500000079305479

Class

5

Filing

79305479

Registration

6599693

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

07/12/2022

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

01/20/2021

Registration date

12/28/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/28/2021

Last transaction

06/16/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

KR

Examiner

MESSICK, TABITHA LEE

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

HUMEDIX Co., Ltd.

Representatives

James R Menker Holley & Menker, PA

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Household deodorants; vaccines; botulinum toxin for medical use for use in the treatment of facial wrinkles; pharmaceutical preparation for skin care; first aid kits; milk sugar for medical purposes; food for babies; dietary food supplements for infants; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; plasters for medical purposes; medicinal infusions for use in the treatment of facial wrinkles; disposable baby diapers; injectable dermal fillers; dermatological pharmaceutical products; skin grafts

Publications

History of USPTO decisions and trademark events.

22 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/12/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/16/2022

FIMP

FINAL DISPOSITION PROCESSED

06/16/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/28/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/28/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/24/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/12/2021

PUBO

PUBLISHED FOR OPPOSITION

10/12/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/22/2021

RFNT

REFUSAL PROCESSED BY IB

09/11/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/03/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/26/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/26/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/26/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/23/2021

RFRR

REFUSAL PROCESSED BY MPU

08/23/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/12/2021

CNRT

NON-FINAL ACTION WRITTEN

08/11/2021

DOCK

ASSIGNED TO EXAMINER

08/03/2021

MAFR

APPLICATION FILING RECEIPT MAILED

03/09/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/05/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/04/2021

Continuous trademark protection

Get notified about every new filing that threatens VIVITOXIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.